PSA

(redirected from Prostate-Specific Antigen Test)
Also found in: Dictionary, Thesaurus, Medical, Financial.

PSA

1. prostatic specific antigen: an enzyme secreted by the prostate gland, increased levels of which are found in the blood of patients with cancer of the prostate
2. (in New Zealand) Public Service Association

PSA

PSA

Problem Statement Analizer. See PSL/PSA.

PSA

(Professional Services Automation) An information system designed to organize, track and manage all opportunities, work, resources, costs, revenues and invoices to improve the productivity and efficiency of the workforce. It is primarily targeted toward professional service organizations (PSOs), such as IT consulting firms and accounting firms, or professional service divisions (PSDs) within a company that bill for services performed by their employees.

From Start to Finish
An integrated system supports all phases of the project from first contact to collecting cash and posting revenue. The initial data may be derived from a CRM system when the project is ready to be assessed, or it can be managed entirely within the PSA system. PSA systems help convert the sizing and scoping of a project (the presales effort) into implementation timetables.

Key Functions
PSA systems provide resource management and information sharing and reserve and assign personnel based on skills, availability, career goals and travel preferences. A key element is Web-based data entry so that consultants can record their time and expenses on the job for efficient billing and project and customer management. For companies that sell products, the system may integrate inventory and billing.

As an example of integrated systems, the following functions are supported in Lawson Software's PSA suite. See CRM.


Contact Management
Opportunity Management
Client Management
Contract Management
Project/Engagement Management
Knowledge Management
Resource Management
Resource Assignments and Scheduling
Time and Expense Reporting
Project Accounting
Billing and Revenue Management
References in periodicals archive ?
According to the survey of citizens of the 27 member states and Croatia, only 13% of European men have taken the prostate-specific antigen test and only 8% of respondents the colorectal cancer test.
By comparison, the widely hailed prostate-specific antigen test for diagnosing prostate cancer is just 36% accurate, and the CA125 test for ovarian cancer is 57% accurate.
Prostate cancer is not a death sentence, Early detection and treatment can halt prostate cancer before it reaches an advanced stage, African-American men 45 or older should begin taking an annual prostate-specific antigen test (PSA) along with a digital rectal exam and have regular checkups.
The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found.

Full browser ?